BAI Yu, YANG Yaming. Application of azithromycin combined with simvastatin in treating patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 33-35. DOI: 10.7619/jcmp.201910010
Citation: BAI Yu, YANG Yaming. Application of azithromycin combined with simvastatin in treating patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 33-35. DOI: 10.7619/jcmp.201910010

Application of azithromycin combined with simvastatin in treating patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension

More Information
  • Received Date: February 09, 2019
  • Accepted Date: April 16, 2019
  • Available Online: February 22, 2021
  • Published Date: May 27, 2019
  •   Objective  To investigate the value of azithromycin combined with simvastatin in patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary hypertension.
      Methods  Eighty COPD patients with pulmonary hypertension were enrolled in our hospital. The control group with 40 patients were treated with simvastatin alone, and 40 patients in the observation group were treated with azithromycin combined with simvastatin. The treatment effects of the two groups were compared.
      Results  After different treatments, the differences in blood oxygen partial pressure, blood oxygen saturation, 6-min walking distance, lung function indexes and pulmonary artery pressure levels were statistically significant (P < 0.05). After treatment, the level of C-reactive protein in the observation group was significantly lower than that in the control group (P < 0.05).
      Conclusion  Azithromycin combined with simvastatin is of great significance in improving the disease condition of patients with COPD complicated with pulmonary hypertension.
  • [1]
    马肖龙. 阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压的临床疗效[J]. 中国临床药理学杂志, 2015, 31(4): 250-252. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201504003.htm
    [2]
    刘旭东, 吴俊丽, 刘云, 等. 辛伐他汀联合阿奇霉素治疗老年慢性阻塞性肺疾病合并肺动脉高压患者的疗效[J]. 实用医学杂志, 2016, 32(7): 1199-1200. doi: 10.3969/j.issn.1006-5725.2016.07.055
    [3]
    中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞肺疾病诊治指南(2007修订版)[J]. 中华结核和呼吸杂志, 2007, 30(1): 8-17. doi: 10.3760/j:issn:1001-0939.2007.01.004
    [4]
    马峰, 朱卫华. 小剂量大环内酯类药物联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压疗效评价[J]. 医学综述, 2016, 22(1): 170-172. doi: 10.3969/j.issn.1006-2084.2016.01.049
    [5]
    Chen W, Thomas J, Sadatsafavi M, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. Lancet Respiratory Medicine, 2015, 3(8): 631-639. doi: 10.1016/S2213-2600(15)00241-6
    [6]
    王艳, 史玉红, 李圣, 等. 阿奇霉素联合辛伐他汀对慢性阻塞性肺疾病合并肺动脉高压患者肺功能的影响[J]. 现代生物医学进展, 2017, 17(7): 138-140, 148. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201707034.htm
    [7]
    蒋衣果, 周梅芳, 朱建军, 等. 辛伐他汀联合法舒地尔治疗COPD合并肺动脉高压患者临床效果观察[J]. 西部医学, 2016, 28(5): 709-712. doi: 10.3969/j.issn.1672-3511.2016.05.031
    [8]
    O′Donnell D E, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2008 update-highlights for primary care. [J]. Canadian Respiratory Journal Journal of the Canadian Thoracic Society, 2016, 15(4): 219-225. http://www.tandfonline.com/servlet/linkout?suffix=CIT0015&dbid=8&doi=10.1080%2F17476348.2018.1439741&key=18292855
    [9]
    洪路贤, 王秋婷. 阿奇霉素片联合阿托伐他汀钙片治疗慢性阻塞性肺疾病合并肺动脉高压的临床研究[J]. 中国临床药理学杂志, 2018, 34(18): 8-10. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201818002.htm
    [10]
    姜妤, 郭小青, 陈曦, 等. 西地那非联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压患者的效果分析[J]. 河北医药, 2017, 39(20): 3136-3138. doi: 10.3969/j.issn.1002-7386.2017.20.027
    [11]
    刘勇进, 张意仲, 夏仁瑞, 等. 阿托伐他汀联合常规治疗方案对老年COPD合并肺动脉高压患者VEGF水平及肺功能的影响[J]. 实用药物与临床, 2016, 19(9): 1108-1110. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201609013.htm
    [12]
    酚妥拉明联合疏血通治疗COPD合并肺动脉高压的疗效及其对患者凝血状态及血清NO、NOS水平的影响[J]. 海南医学, 2018, 29(7): 919-923.
    [13]
    覃燕文. 使用阿奇霉素和辛伐他汀对慢阻肺并发肺动脉高压患者进行治疗的效果分析[J]. 当代医药论丛, 2017, 15(9): 107-108. doi: 10.3969/j.issn.2095-7629.2017.09.080
    [14]
    曾明旋, 程知音, 胡斌. 阿奇霉素联合他汀类药物在慢阻肺并发肺动脉高压中的应用效果[J]. 临床肺科杂志, 2016, 21(3): 471-473. doi: 10.3969/j.issn.1009-6663.2016.03.024
    [15]
    王春芳. 阿奇霉素结合他汀类药物用于治疗慢阻肺并发肺动脉高压的疗效探讨[J]. 临床医药文献电子杂志, 2017, 4(29): 23-24. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201729008.htm
    [16]
    Detorres J P, Wilson D O, Sanchezsalcedo P, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score[J]. Am J Respir Crit Care Med, 2015, 191(3): 285-291. doi: 10.1164/rccm.201407-1210OC
    [17]
    赵钰玲, 鱼军, 李建英. 阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压临床疗效的Meta分析[J]. 实用心脑肺血管病杂志, 2018, 26(3): 8-12. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL201803005.htm
    [18]
    唐晨. 辛伐他汀治疗对慢性阻塞性肺疾病合并肺动脉高压患者心肺功能及炎性细胞因子的影响[J]. 现代中西医结合杂志, 2017, 26(8): 851-853. doi: 10.3969/j.issn.1008-8849.2017.08.018
  • Related Articles

    [1]DONG Hao, DING Xiaorui, YUE Yanqiu. Application effect of protease combined with quadruple therapy in the remedial treatment of Helicobacter pylori eradication failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 86-89. DOI: 10.7619/jcmp.20231978
    [2]NIU Zhanyue, SHI Yanyan, LI Sizhu, XUE Yan. Characteristics of gastric microbiota in Helicobacter pylori associated chronic gastritis[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 56-61. DOI: 10.7619/jcmp.20233613
    [3]TAN Junhui, WANG Xiaoyuan, DU Meiling, ZHANG Aiai, LI Feixing, YI Mengyang, LI Fangjiang. Effect of Helicobacter pylori eradication on blood lipid and inflammation level in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 112-115. DOI: 10.7619/jcmp.20221481
    [4]GUO Jinzhi, TANG Shengjun, WANG Delu, QIAN Likang, ZHANG Yuanrui. Study on Helicobacter pylori serotypes, upper gastrointestinal diseases and effect of Helicobacter pylori eradication[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 128-131. DOI: 10.7619/jcmp.20220380
    [5]ZHANG Sheng. Effect of clarithromycin combined with Weiyanning Granule on Hp eradication rate and efficiency in children with gastritis[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 116-118. DOI: 10.7619/jcmp.201918033
    [6]GUO Ying, PEI Dongmei. Correlation between Helicobacter pylori infection and bone in men[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 34-37. DOI: 10.7619/jcmp.201909010
    [7]ZHANG Zhihua, GONG Xiaohuan, MA Jinfu, YU Qingsan. Efficacy of Helicobacter pylori eradication quadruple therapy combined with Bifidobacterium in the treatment of Helicobacter pylori infection in adolescents[J]. Journal of Clinical Medicine in Practice, 2018, (3): 48-50. DOI: 10.7619/jcmp.201803013
    [8]SUN Bin, XU Hui. Effect comparison of three different disinfection methods in treatment of elderly patients with helicobacter pylori infection[J]. Journal of Clinical Medicine in Practice, 2014, (9): 120-122. DOI: 10.7619/jcmp.201409038
    [9]LIAN Hua, WANG Wenbing, ZHANG Wenli, ZHOU Tao, HU Lian. Effect of eradicating helicobacter pylori on the positive helicobacter pylori patients with reflux esophagitis[J]. Journal of Clinical Medicine in Practice, 2013, (17): 129-131. DOI: 10.7619/jcmp.201317047
    [10]WANG Feng-qin. The clinical observation of Paroxetine in the treatment of Helicobacter pylori negative chronic gastritis[J]. Journal of Clinical Medicine in Practice, 2011, (11): 109-110,115. DOI: 10.3969/j.issn.1672-2353.2011.11.038

Catalog

    Article views (368) PDF downloads (7) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return